Our latest insights

Built on world-class research and clinical trials, Australia’s biotech industry is increasingly shifting towards commercialisation, global expansion, and long-term growth.

If government grants are part of your 2025 strategy, take note of the available quarter one funding opportunities. With increasing inflationary pressures, government grants can be an essential alternative funding source for businesses with critical investment projects.

The recent release of the Australian Taxation Office’s (ATO) R&D Tax Transparency Report for the 2021-22 period delivers valuable insights into the state of research and development (R&D) using claim data across various sectors, particularly in Technology, Media, and Telecommunications (TMT).

As we approach the end of Q1 FY25, it’s important consider how new and existing government grant programs could help your business achieve bigger, better, and faster outcomes.

Navigating the funding landscape can be tricky for biotech companies at all stages, from initial research and clinical trials to scaling up capabilities. Our recent roundtable discussions with over 90 Biotech CEOs, held in partnership with AusBiotech, shed light on the challenges and opportunities shaping the industry.

In this episode, Partners and Innovation and Incentives specialists Rebecca Iwanuscha and Sukvinder Heyer discuss the importance of innovation, what to expect in the May Federal Budget, and what we want to see from the Government in terms of support in this space.

In an increasingly digitised global world, technology is omni-present, transcends geographic boundaries, and influences every aspect of 21st century life. With this rapid change, invisible assets, or intangible assets (“intangibles”) are progressively more important value drivers for many Multinational Enterprises (MNEs). These intangibles have become the focus of tax controversy worldwide.

This financial year was a year of many changes in the R&D space – a new government, borders re-opening Australia to the world, easing supply chain pressures driving opportunities for trade, and an appetite to boost on-shore manufacturing.

Federal Budget Opposition Reply 2022-23

In this year’s Federal Budget, the Government has allocated $1 billion to the manufacturing sector to supercharge investment with a focus on seven key areas.

The Federal Government introduced the much anticipated “patent box regime” rules into Parliament on 10 February 2022, as announced in the Federal Budget 2021-22.

In consultation with patent attorneys from Griffith Hack, we have applied our expertise across patent law, R&D tax, corporate tax and industry specific knowledge to consider the challenges and opportunities for patent box here in Australia.